Home › Rheumatoid Arthritis › New York › The Bronx
Rheumatoid Arthritis clinical trials in The Bronx, NY
3 studies for Rheumatoid Arthritis are looking for participants at sites in and around The Bronx (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
RecruitingPhase 2
- Equity Medical, The Bronx
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RecruitingPhase 2
- Northwell Health Physician Partners Rheumatology At Great Neck /ID# 275621, Great Neck · 8 mi away
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RecruitingPhase 2
- Northwell Health, Great Neck · 8 mi away
About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
More about Rheumatoid Arthritis on MedlinePlus
Rheumatoid Arthritis trials in other cities
- Houston, TX12 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Miami, FL8 studies
- Plantation, FL7 studies
- Altoona, PA7 studies
- Dallas, TX7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Mesquite, TX6 studies
- San Diego, CA6 studies
- Ann Arbor, MI5 studies
Other studies in The Bronx
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer18 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer12 studies
- Lung Cancer12 studies
- Cardiovascular Disease11 studies
- Cancer (all types)10 studies
- Asthma10 studies
- Heart Failure10 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Myelodysplastic Syndromes9 studies
- Colorectal Cancer9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.